Systemic lupus erythematosus
Systemic lupus Erythematosus – Lupus -
a basic understanding
The body has an immune system designed to
protect the individual from infections and external threats, but every
now and then, the immune system becomes autonomous and causes disease by
attacking against the person itself. This phenomenon is called autoimmunity and there
are multiple diseases which arise through the inability of the body to
distinguish itself from an outside environmental agent or infection. What follows is activation of the blood white
cells, especially lymphocytes and the production of antibodies which
attach to, and damage, or destroy various organ tissues. These diseases are based on a genetic component,
versus frequently an exposure to an infection or unknown agent in the
environment, frequently years before onset of the disease.
These autoimmune diseases include amongst many diseases: Rheumatoid arthritis affects primarily the
joints. Crohn’s diseases affects the bowel Ulcerative colitis affects primarily the colon. Psoriasis can affect
skin, nails and tendons and
joints. Systemic Lupus erythematosus, is an inflammatory
autoimmune disease affecting multiple systems and can vary from mild to
life threatening.
In the case of lupus,
what follows, is activation of the blood white cells, especially
lymphocytes, and the production of antibodies which attach to and damage
or destroy various organ tissues. The disease occurs in 1 – 10 per 100000 people
worldwide. There are some populations which are more
susceptible. This is especially African American women, 230 /
100000, the Hispanic 120 / 100000, the Asian population but also the
mixed race population of the western cape A study in Israel showed between 49 to 155 cases
per 100000. Sephardic and Bedouin were more common than the
Ashkenazi jews. The severity of disease may also be affected by
the genetics and hormone status. Ashkenazi jews generally were generally less
severe at onset and had a better outcome. The disease occurs especially in women age 15 to
45 but 10% start in childhood. The clinical manifestations, vary from minor
symptoms to life threatening disease, include: Constitutional symptoms,
which are common,
with
fatigue, brain fog and fevers. Different Skin rashes
varying from
1.
An acute
classical butterfly distribution rash on the face with sensitivity to
light.
2.
A subacute non
scarring skin rashes, on the neck chest and shoulders.
3.
A chronic
scarring type called discoid lupus with scarring of the skin. Hair loss called
alopecia without scarring. Mouth ulcers,
which are usually painless and increase with disease activity. Joint manifestations
are common with morning stiffness, pain without swelling – called
arthralgia, or if more severe, obvious swelling in the joints –
arthritis. Cardiac involvement
with inflammation of the heart valves – endocarditis, or of the muscle –
myocarditis or the lining of the heart – pericarditis, with varying
severity of chest pain or heart failure with breathlessness. Respiratory involvement
with inflammation of the lining of the lung with chest pain on breathing
called pleurisy, or involvement of lung tissue causing breathlessness. Vascular involvement
with spasm, causing Raynaud’s – white, blue and red color changes in the
fingers in the cold. A lacy pattern of skin pink – blue color called
livedo, is also seen with temperature changes. Severe inflammation of
the blood vessels to the skin or internal organs called vasculitis, can
occur. Hypertension is common, aggravated by kidney disease. Brain involvement
with headaches, depression, psychosis or even seizures, peripheral
neuropathy with sensory disturbance of the hands and feet. Rarely,
strokes of brain or spinal cord tissue can occur. Blood disorders,
from marrow involvement, or autoimmune peripheral blood involvement,
with moderate to severe anemia or bleeding disorder because of platelet
reduction or low white count and increased infection risks. Clotting disorders
may also occur called antiphospholipid syndromes. This can cause
thrombosis of vessels or embolism to lung. Gastroenterological
involvement
with swallowing issues, abdominal pain or rarely pancreatitis or
hepatitis. Kidney disease
– with varying severity of inflammation of kidney tissue causing blood
or protein in urine on testing. This is the most important involvement
in lupus, and in the past was the primary cause of death in patients
from kidney failure. Pregnancy issues.
Very important because fertility and second trimester fetal loss is
associated with lupus, especially if antiphospholipid antibodies are
found. Hypertension and aggravated kidney disease and bleeding and
clotting issues with pregnancy, cause potential harm to mother and
child, if the disease is active and uncontrolled during pregnancy. It is
essential to control disease before pregnancy can be undertaken.
The diagnosis is made on
clinical suspicion with the clinical findings of the patient, with a
full history and examination, since
the illness is so multisystem in nature. At the same time an indication
of severity is made, by assessing for major organ involvement,
especially kidney involvement by examining the urine. Thereafter blood can be sent to the
pathologists, looking at especially, the full blood count, the level of
inflammation -the sedimentation rate (ESR), the kidney function (urea
and creatinine) and the special tests for lupus antibodies (antinuclear
antibody and anti DNA and ENA antibodies). Once a diagnosis is suspected, the specialist of
choice is the rheumatologist who will liaise with other specialists,
especially renal physicians. Kidney biopsy might be required. If a rheumatologist is unavailable, as there are
relatively few in South Africa outside the major centers, a physician
can be consulted who will liaise with a rheumatologist as best as
possible. The disease is
characterized by flares of activity, with constitutional, skin and joint
disease, seen very frequently. The organ complications are less common,
but the specialist should see the patient more frequently,
depending on symptoms, or for
regularly monitoring every 6 months. The patient should have their urine
checked at each visit. Treatment has revolutionized the management of
the disease. Antimalarial treatment with hydroxychloroquine
is the foundation for almost all lupus patients. Antiinflammatory medications may be used for
pain and inflammation. However more severe disease will require an
immune suppression approach, with cortisone, in doses dependent on organ
disease. For those diseases requiring more than
cortisone, or to limit cortisone dosing,
immune
suppressant drugs like azathioprine, methotrexate, CellCept,
cyclophosphamide or new more expensive, biologic drugs, especially
rituximab, and
belimumab (the latter, unavailable in south Africa.) With proper treatment, patients can have normal
lives, have normal pregnancies, and the chances of survival have
improved dramatically over the last 30 years, and survival has improved
from 50% to >90% in the current era. Dr Gotlieb
|
|
|||||||||||||||||||||||||||||||